Related Experiment Videos
Pathogenic synergy: mixed intra-abdominal infections
Antonie Van Leeuwenhoek
|January 1, 1984
Summary
This study reveals how Bacteroides strains hinder polymorphonuclear leukocytes in mixed infections by competing for complement factors. Pathogenic synergy between Escherichia coli and Bacteroides fragilis was demonstrated in a new mouse skin infection model.
Area of Science:
- Microbiology
- Immunology
- Pathogenesis Research
Background:
- Mixed infections present complex challenges in understanding disease progression.
- Bacteroides species are frequently implicated in polymicrobial infections, often associated with abscess formation.
- The interaction between bacterial pathogens and host immune cells, particularly polymorphonuclear leukocytes (PMNs), is crucial in determining infection outcomes.
Purpose of the Study:
- To investigate the mechanisms underlying the pathogenesis of mixed bacterial infections.
- To elucidate the role of Bacteroides species in modulating host immune responses during infection.
- To establish and utilize an in vivo model for studying synergistic bacterial pathogenesis.
Main Methods:
- In vitro assays examining the interaction between Bacteroides strains and polymorphonuclear leukocytes (PMNs).
- Studies investigating the role of complement factors (opsonins) in PMN-mediated killing of aerobic bacteria.
- Development and application of a reproducible mouse skin infection model to assess in vivo pathogenicity and synergy.
Main Results:
- Bacteroides strains were confirmed to interfere with PMN killing of aerobes, likely through competition for complement factors.
- Preliminary data suggest Bacteroides fragilis exhibits poor chemotaxis and reduces the chemoattractivity of Proteus mirabilis.
- A synergistic pathogenic effect between Escherichia coli and Bacteroides fragilis was demonstrated in the established mouse skin infection model.
Conclusions:
- Bacteroides species possess mechanisms to evade host immune defenses, contributing to mixed infection pathogenesis.
- Further research is needed to clarify the specific complement factors and bacterial structures involved in immune evasion.
- The developed in vivo model provides a valuable tool for future studies on mixed infection synergy and the role of host-pathogen interactions.